Q&A

Version 2 ( EMIS, Vision, Microtest and Torex)

C10.. Diabetes mellitus

C109K Hyperosmolar non-ketotic state in type 2 diabetes mellitus

C10C. Diabetes mellitus autosomal dominant

C10D. Diabetes mellitus autosomal dominant type 2

C10E. % Type 1 diabetes mellitus

C10F.% Type 2 diabetes mellitus (Excluding C10F8)

C10G.% Secondary pancreatic diabetes mellitus

C10H.% Diabetes mellitus induced by non-steroid drugs

C10M.% Lipoatrophic diabetes mellitus

C10N.% Secondary diabetes mellitus

 

CTV3 (SystmOne)

C10.. Diabetes mellitus

XaOPu Latent autoimmune diabetes mellitus in adult

XaOPt Maternally inherited diabetes mellitus

X40J4% Type 1 diabetes mellitus

X40J5% Type 2 diabetes mellitus (Excluding C10F8)

X40J6 Insulin treated Type 2 diabetes mellitus

X40JA % Secondary diabetes mellitus

X40JG% Genetic syndromes of diabetes mellitus

C1011 Type 2 diabetes mellitus with ketoacidosis

C1010 Type 1 diabetes mellitus with ketoacidosis

 

 

C1030 Type 1 diabetes mellitus with ketoacidotic coma

C1031 Type II diabetes mellitus with ketoacidotic coma

XaIrf Hyperosmolar non-ketotic state in type II diabetes mellitus

 

X40JZ Diabetes-deafness syndrome maternally transmitted

XSETp Diabetes mellitus due to insulin receptor antibodies

XM1Xk% Unstable diabetes

C10G.% Secondary pancreatic diabetes mellitus

C10H.% Diabetes mellitus induced by non-steroid drugs

C10M.% Lipoatrophic diabetes mellitus

C10N.% Secondary diabetes mellitus

You need to check the Read code used to record the amputation is a QOF code.

 

Foot Amputation Codes
  CTV3 Version 2
O/E – Amputated right leg XaBLT 2G42.

 

 

 

  CTV3 Version 2
O/E – Amputated right above knee XaBLV 2G44.
O/E – Amputated right below knee XaBLX 2G46.
O/E – Amputated left leg XaBLU 2G43.
O/E – Amputated left above knee XaBLW 2G45.
O/E – Amputated left below knee XaBLXY 2G47.

 

 

Both codes are part of QOF so there is not an issue there and both results have been sent by the lab for about a year now. The 42W5 being the International Federation of Clinical Chemistry and Laboratory Medicine standardised and the more familiar code 42W4.HbA1c level (DCCT aligned)

 

We should be working towards familiarising ourselves with the new levels although there has not been any change to the rule sets regarding the 42W4, this is still acceptable at the moment

 

Comparing DCCT-HbA1c and IFCC-HbA1c Results

 

The chart below allows the practices to convert the levels and I would be surprised if practices did not have a copy, we did hand them out to the audit clerks last year

 

 

 

 

DCCT-HbA1c (%)             IFCC-HbA1c (mmol/mol)

6                                                              42

6.5                                                          48

7                                                              53

7.5                                                          59

8                                                              64

9                                                              75

 

To achieve this indicator you would need to have patients diagnosed with proteinuria or micro-albuminuria that you would treat with an ACE inhibitors (or A2 antagonists). If you are aware of patients with a diagnosis of either proteinuria or micro-albuminuria, you need to check the Read Codes used.

 

 

It is recommended you still discuss the three topics with patients as CQRS are extracting this data. Although the results will not be used to assess practice achievement

CTV3                      Version 2

XaRFa                    8IB4.                     Pregnancy advice for patients with epilepsy not indicated

XaRFb                   8IB3.                     Pre-conception advice for patients with epilepsy not indicated

XaRFc                    8IB2.                     Contraceptive advice for patients with epilepsy not indicated

The new Read Codes are listed below with the conversion table:

International Federation of Clinical Chemistry (IFCC) Standardization of HbA1c conversion table

 

IFCC HbA1c NGSP HbA1c (%)
31 5
42 6
53 7
64 8
75 9
86 10
97 11
108 12

 

Version 2

42W5.   Haemoglobin A1c level – International Federation of Clinical Chemistry and Laboratory Medicine standardised

 

CTV3

XaPbt    Haemoglobin A1c level – International Federation of Clinical Chemistry and Laboratory Medicine standardised

If the patient is treated by the CPA and evidence of a documented care plan discussed with their community key worker is available, this can be scanned onto the patient’s record and would be acceptable for QOF. It is the MH patients who do not have a key worker who will require a primary care care plan.

 

The mental health care plan codes are listed below

  CTV3 Version 2
Mental Health Care Programme Approach XaIXu 8CY..
Care Programme Approach review XaK8p 8CG6.
Ongoing Care Programme Approach review XaK8s 8CG61
Initial Care Programme Approach review XaK8r 8CG60
Discharge Care Programme Approach review XaK8t 8CG62
Agreeing on mental health care plan Xaa8p 8CS7.
Review of mental health care plan Xaa8q 8CMG1

 

 

 

 

 

 

 

 

 

MENTAL HEALTH PLAN & REVIEW

 

Patient Name Date of Birth
GP Name
Date of Mental
Health Plan
Actual Date of Mental
Health Review

 

Outcome Tool Result at assessment Result at review

 

 

PROBLEM / PT NEEDS GOALS / ACTIONS REQUIRED TREATMENTS REVIEW OUTCOME
 

(eg. Reduce symptoms, improve functioning)

(eg. Referral to Allied Health,  medication, engagement of family / other supports)  

(Impact of action / task on problem)

1.

 

 

 

 

2.

 

 

 

 

3.

 

 

 

 

 

Early Warning Signs (Be specific. Re-assess at Review Consultation.)
1 2
3 4

 

Relapse Prevention Plan (Re-assess at Review Consultation.)
1 2
3 4
5 6

 

Emergency Care (eg Family contact person / details)
1

 

2

 

 

3       Access Team, Phone

 

 

 

 

The following section to be signed by patient and GP:

 

 

I understand the above Mental Health Plan and agree to the outlined goals / actions

 

Patient Signature:

 

 

GP Signature:

 

 

Has a copy of the MH Plan been given to the Patient? Yes   ¨                 No  ¨
Proposed date for Mental Health Review (1 – 6 months after MH Plan adopted)

 

 

Additional Notes
 

 

 

 

 

 

All Q&As
Clinical Indicators
  • Clear all
General information
  • Clear all

Join Our Mailing List

Keep up to date with all our latest new and upcoming events.